Natixis’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.4M	Sell	488,804 -4,245	-0.9%	-$530K	0.25%	59
2025 Q4	$60.1M	Sell	493,049 -4,847	-1%	-$556K	0.24%	61
2025 Q3	$49.9M	Sell	497,896 -2,104	-0.4%	-$190K	0.27%	69
2025 Q2	$41.5M	Hold	500,000	–	–	0.21%	80
2025 Q1	$40.3M	Buy	+500,000	New	+$44.7M	0.24%	71
2023 Q1	–	Sell	-3	Closed	-$249	–	1230
2022 Q4	$249	Buy	+3	New	+$243	﹤0.01%	1053
2020 Q4	–	Sell	-1,000,000	Closed	-$111M	–	1111
2020 Q3	$111M	Buy	+1,000,000	New	+$112M	0.82%	29
2020 Q2	–	Sell	-2,000,000	Closed	-$155M	–	869
2020 Q1	$155M	Hold	2,000,000	–	–	1.22%	12
2019 Q4	$190M	Buy	2,000,000 +1,960,460	+4,958%	+$170M	1.18%	7
2019 Q3	$3.02M	Buy	39,540 +8,929	+29%	+$742K	0.02%	433
2019 Q2	$2.69M	Sell	30,611 -1,229	-4%	-$105K	0.02%	409
2019 Q1	$2.83M	Sell	31,840 -39,015	-55%	-$3.32M	0.02%	458
2018 Q4	$5.08M	Buy	70,855 +30,561	+76%	+$2.46M	0.04%	319
2018 Q3	$3.86M	Sell	40,294 -9,204	-19%	-$892K	0.02%	412
2018 Q2	$4.71M	Buy	49,498 +2,594	+6%	+$238K	0.02%	389
2018 Q1	$4.12M	Buy	46,904 +14,806	+46%	+$1.35M	0.03%	395
2017 Q4	$2.72M	Buy	32,098 +9,250	+40%	+$775K	0.02%	373
2017 Q3	$1.98M	Sell	22,848 -327,152	-93%	-$26.2M	0.02%	417
2017 Q2	$27M	Buy	350,000 +225,028	+180%	+$16M	0.31%	84
2017 Q1	$8.65M	Buy	124,972 +41,667	+50%	+$2.8M	0.11%	183
2016 Q4	$4.93M	Buy	83,305 +23,656	+40%	+$1.46M	0.05%	263
2016 Q3	$3.95M	Buy	+59,649	New	+$3.69M	0.05%	217
2015 Q4	–	Sell	-8,364	Closed	-$521K	–	374
2015 Q3	$521K	Buy	8,364 +2,424	+41%	+$191K	0.01%	193
2015 Q2	$499K	Buy	+5,940	New	+$462K	0.01%	257